Publications
Showing 1 - 100 results of 2,879 publications
2025
- Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient populationArun A, Liarakos D, Mendiratta G, Kim J, Goshua G, Olson P, Stites E. Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population. The Pharmacogenomics Journal 2025, 25: 5. PMID: 40044654, DOI: 10.1038/s41397-025-00364-3.
- Haptoglobin in pregnancy: Trimester-specific reference intervalsRivera M, Choucair I, Vera M, Lee E, El-Khoury J, Villalba C. Haptoglobin in pregnancy: Trimester-specific reference intervals. American Journal Of Clinical Pathology 2025, aqaf012. PMID: 40037777, DOI: 10.1093/ajcp/aqaf012.
- 110 Characterization of Frequency and Spectrum of PIK3CA Somatic Mutations in Advanced Breast CancerAmraei R, Kahn A, Walther Z, Finberg K, Gibson J, Kahila M. 110 Characterization of Frequency and Spectrum of PIK3CA Somatic Mutations in Advanced Breast Cancer. Laboratory Investigation 2025, 105: 102334. DOI: 10.1016/j.labinv.2024.102334.
- Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative NeoplasmsGoldberg L, Yoon J, Johnston H, Davidson M, Siddon A, Shallis R, Chen E, Burkart M, Oh T, Iyer S, Madarang E, Muthiah C, Kassner J, Rampal R, Murthy S, Bradley T, Abaza Y, Garcia J, Gupta V, Pettit K, Odenike O, Cursio J, Patel A. Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms. Blood Neoplasia 2025, 100089. DOI: 10.1016/j.bneo.2025.100089.
- Norovirus co-opts NINJ1 for selective protein secretionSong J, Zhang L, Moon S, Fang A, Wang G, Gheshm N, Loeb S, Cao P, Wallace J, Alfajaro M, Strine M, Beatty W, Jamieson A, Orchard R, Robinson B, Nice T, Wilen C, Orvedahl A, Reese T, Lee S. Norovirus co-opts NINJ1 for selective protein secretion. Science Advances 2025, 11: eadu7985. PMID: 40020060, PMCID: PMC11870086, DOI: 10.1126/sciadv.adu7985.
- Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsSkoulidis F, Araujo H, Do M, Qian Y, Sun X, Cobo A, Le J, Montesion M, Palmer R, Jahchan N, Juan J, Min C, Yu Y, Pan X, Arbour K, Vokes N, Schmidt S, Molkentine D, Owen D, Memmott R, Patil P, Marmarelis M, Awad M, Murray J, Hellyer J, Gainor J, Dimou A, Bestvina C, Shu C, Riess J, Blakely C, Pecot C, Mezquita L, Tabbó F, Scheffler M, Digumarthy S, Mooradian M, Sacher A, Lau S, Saltos A, Rotow J, Johnson R, Liu C, Stewart T, Goldberg S, Killam J, Walther Z, Schalper K, Davies K, Woodcock M, Anagnostou V, Marrone K, Forde P, Ricciuti B, Venkatraman D, Van Allen E, Cummings A, Goldman J, Shaish H, Kier M, Katz S, Aggarwal C, Ni Y, Azok J, Segal J, Ritterhouse L, Neal J, Lacroix L, Elamin Y, Negrao M, Le X, Lam V, Lewis W, Kemp H, Carter B, Roth J, Swisher S, Lee R, Zhou T, Poteete A, Kong Y, Takehara T, Paula A, Parra Cuentas E, Behrens C, Wistuba I, Zhang J, Blumenschein G, Gay C, Byers L, Gibbons D, Tsao A, Lee J, Bivona T, Camidge D, Gray J, Leighl N, Levy B, Brahmer J, Garassino M, Gandara D, Garon E, Rizvi N, Scagliotti G, Wolf J, Planchard D, Besse B, Herbst R, Wakelee H, Pennell N, Shaw A, Jänne P, Carbone D, Hellmann M, Rudin C, Albacker L, Mann H, Zhu Z, Lai Z, Stewart R, Peters S, Johnson M, Wong K, Huang A, Winslow M, Rosen M, Winters I, Papadimitrakopoulou V, Cascone T, Jewsbury P, Heymach J. Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature 2025, 639: e19-e19. PMID: 40016449, PMCID: PMC11903295, DOI: 10.1038/s41586-025-08767-9.
- Correction: Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signalingIsraelow B, Song E, Mao T, Lu P, Meir A, Liu F, Alfajaro M, Wei J, Dong H, Homer R, Ring A, Wilen C, Iwasaki A. Correction: Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. Journal Of Experimental Medicine 2025, 222: e2020124102192025c. PMID: 40009071, PMCID: PMC11864074, DOI: 10.1084/jem.2020124102192025c.
- Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapyShaw R, Yoon J, Johnston H, Davidson M, Siddon A, Shallis R, Chen E, Burkart M, Oh T, Iyer S, Madarang E, Muthiah C, Kassner J, Rampal R, Guru Murthy G, Bradley T, Abaza Y, Garcia J, Gupta V, Pettit K, Odenike O, Patel A. Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy. Blood Advances 2025 PMID: 39969200, DOI: 10.1182/bloodadvances.2024015712.
- Natriuretic peptide testing in veterans hospitalized with heart failure: Potential differences by sexGandhi P, Runels T, Han L, Skanderson M, Bastian L, Brandt C, Hauser R, Feder S, Rodwin B, Farmer M, Bean-Mayberry B, Placide S, Gaffey A, Akgün K. Natriuretic peptide testing in veterans hospitalized with heart failure: Potential differences by sex. Heart & Lung 2025, 71: 25-31. PMID: 39970822, DOI: 10.1016/j.hrtlng.2025.02.001.
- Capacity assessment for EHR-based medical device post-market surveillance for synthetic mid-urethral slings among women with stress urinary incontinence: a NEST consortium studyMatheny M, Perkins A, Rieger-Christ K, Ross J, Mao J, Sedrakyan A, Shah N, Winter R, Reynolds W, Mourtzinos A, Schulz W, Bartlett V, Solotke M, Pandya S, Aryal S, Cho A, Frankenberger E, Park D, Bostrom D, Robbins S, Yustein A, Chughtai B, Trabuco E. Capacity assessment for EHR-based medical device post-market surveillance for synthetic mid-urethral slings among women with stress urinary incontinence: a NEST consortium study. BMJ Surgery Interventions & Health Technologies 2025, 7: e000193. PMID: 39949784, PMCID: PMC11822424, DOI: 10.1136/bmjsit-2023-000193.
- T49 Effects of Nicotine Flux and Form on Speed and Total Amount of Arterial Blood Nicotine Delivery during Acute E-Cigarette VapingBaldassarri S, McKinney E, Mysirlidis S, Sharma M, Blohowiak R, Joseph P, Eid T, Nadim H, Hanna E, Karaoghlanian N, Adeniji A, Shihadeh A, Eissenberg T, Krishnan-Sarin S, O'Malley S, El-Hellani A, Talih S. T49 Effects of Nicotine Flux and Form on Speed and Total Amount of Arterial Blood Nicotine Delivery during Acute E-Cigarette Vaping. Drug And Alcohol Dependence 2025, 267: 111817. DOI: 10.1016/j.drugalcdep.2024.111817.
- 508 Impacts of red blood cell transfusion and enteral feeding on mesenteric regional tissue oxygenation dynamics in very preterm infantsSalem A, Lukemire J, Ou J, Shenvi N, Barbian M, Saakadze N, Hendrickson J, Easley K, Guo Y, Arthur C, Stowell S, Josephson C, Patel R. 508 Impacts of red blood cell transfusion and enteral feeding on mesenteric regional tissue oxygenation dynamics in very preterm infants. The American Journal Of The Medical Sciences 2025, 369: s331-s332. DOI: 10.1016/s0002-9629(25)00514-2.
- Alemtuzumab and thrombotic thrombocytopenic purpura: Analysis of an international surveillance database and systematic literature reviewJacobs J, Binns T, Schlafer D, Woo J, Booth G, Adkins B. Alemtuzumab and thrombotic thrombocytopenic purpura: Analysis of an international surveillance database and systematic literature review. Transfusion And Apheresis Science 2025, 64: 104081. PMID: 39883995, DOI: 10.1016/j.transci.2025.104081.
- The incompatible match for transfusion medicine fellowshipsBloch E, Triulzi D, Sachais B, Hod E, Cushing M, Jacobs J, Tobian A, Shan H, Chen L, McGonigle A, Tormey C, Szczepiorkowski Z, Siegel D. The incompatible match for transfusion medicine fellowships. Transfusion 2025, 65: 246-248. PMID: 39834046, PMCID: PMC11753254, DOI: 10.1111/trf.18091.
- Associations between blood donors, component modifications, and the alloimmunization of transfusion recipientsYu H, Karafin M, Tormey C, Goel R, Spencer B, Hendrickson J, Hauser R. Associations between blood donors, component modifications, and the alloimmunization of transfusion recipients. Transfusion 2025, 65: 588-603. PMID: 39821794, DOI: 10.1111/trf.18135.
- Chimerism testing in myeloid malignancies: techniques, considerations, and connections to post-transplant outcomesPuzo C, Siddon A. Chimerism testing in myeloid malignancies: techniques, considerations, and connections to post-transplant outcomes. Pathology 2025, 57: 267-275. PMID: 39934013, DOI: 10.1016/j.pathol.2024.12.632.
- Defining a lineage-specific chimerism threshold for the use of donor lymphocyte infusions in treating myeloid malignanciesPuzo C, Seropian S, Rinder H, Tormey C, Siddon A. Defining a lineage-specific chimerism threshold for the use of donor lymphocyte infusions in treating myeloid malignancies. Bone Marrow Transplantation 2025, 1-3. PMID: 39806028, DOI: 10.1038/s41409-025-02510-8.
- Corrigendum: Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health AdministrationMcGinnis K, Justice A, Marconi V, Rodriguez-Barradas M, Hauser R, Oursler K, Brown S, Bryant K, Tate J. Corrigendum: Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration. Frontiers In Medicine 2025, 11: 1532350. PMID: 39845833, PMCID: PMC11750659, DOI: 10.3389/fmed.2024.1532350.
- Inheritance of Imaging Parameters of Arrhythmic Risk in Mitral Valve Prolapse: A Pedigree StudyCristin L, Dixit S, Bibby D, Tang J, Fang Q, Tastet L, Rich A, Jhawar R, Nagata Y, Higuchi S, Levine R, Hsia H, Tseng Z, Schiller N, Delling F. Inheritance of Imaging Parameters of Arrhythmic Risk in Mitral Valve Prolapse: A Pedigree Study. Circulation Cardiovascular Imaging 2025, 18: e017051. PMID: 39764632, PMCID: PMC11753933, DOI: 10.1161/circimaging.124.017051.
2024
- Characterization of LTBP2 mutation causing mitral valve prolapseShpitzen S, Rosen H, Ben-Zvi A, Meir K, Levin G, Gudgold A, Dor S, Haffner R, Zwas D, Leibowitz D, Slaugenhaupt S, Banin E, Mizrachi R, Obolensky A, Levine R, Gilon D, Leitersdorf E, Tessler I, Reshef N, Durst R. Characterization of LTBP2 mutation causing mitral valve prolapse. European Heart Journal Open 2024, 5: oeae106. PMID: 39882270, PMCID: PMC11775471, DOI: 10.1093/ehjopen/oeae106.
- Eliminating leukocyte reduction for whole blood: Is it premature to consider this paradigm‐changing practice?Adkins B, Booth G, Fasano R, Gehrie E, Gestring M, Masel D, Nguyen P, Refaai M, Jacobs J, Raza S, Vella M, Tormey C, Blumberg N. Eliminating leukocyte reduction for whole blood: Is it premature to consider this paradigm‐changing practice? Transfusion 2024, 65: 375-378. PMID: 39709612, PMCID: PMC11826295, DOI: 10.1111/trf.18113.
- Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemiasHamdan H, Liu Y, Wang S, Bledsoe J, Chisholm K, Siddon A, Ohgami R, George T, Kurzer J, Hasserjian R, Arber D, Bagg A, Foucar K, Margolskee E, Laczko D, Chen W, Fuda F, Aggarwal N, Weinberg O. Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemias. EJHaem 2024, 6: e1052. PMID: 39866946, PMCID: PMC11756974, DOI: 10.1002/jha2.1052.
- Evaluation of Siemens Atellica AMH assay and comparison with Roche, Beckman and Ansh LabsShang E, Agustin H, Lee J, Scheidegger M, Jones J, Abou-Diwan C, El-Khoury J, Li J. Evaluation of Siemens Atellica AMH assay and comparison with Roche, Beckman and Ansh Labs. Clinical Biochemistry 2024, 135: 110863. PMID: 39675655, DOI: 10.1016/j.clinbiochem.2024.110863.
- Demographic diversity in platelet function and response to antiplatelet therapyJain K, Tyagi T, Gu S, Faustino E, Hwa J. Demographic diversity in platelet function and response to antiplatelet therapy. Trends In Pharmacological Sciences 2024, 46: 78-93. PMID: 39672782, PMCID: PMC11710996, DOI: 10.1016/j.tips.2024.11.005.
- Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patencyPark J, Riaz M, Qin L, Zhang W, Batty L, Fooladi S, Kural M, Li X, Luo H, Xu Z, Wang J, Banno K, Gu S, Yuan Y, Anderson C, Ellis M, Zhou J, Luo J, Shi X, Shin J, Liu Y, Lee S, Yoder M, Elder R, Mak M, Thorn S, Sinusas A, Gruber P, Hwa J, Tellides G, Niklason L, Qyang Y. Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency. Cell Stem Cell 2024, 32: 137-143.e6. PMID: 39644899, PMCID: PMC11698629, DOI: 10.1016/j.stem.2024.11.006.
- Ezrin drives adaptation of monocytes to the inflamed lung microenvironmentGudneppanavar R, Di Pietro C, H Öz H, Zhang P, Cheng E, Huang P, Tebaldi T, Biancon G, Halene S, Hoppe A, Kim C, Gonzalez A, Krause D, Egan M, Gupta N, Murray T, Bruscia E. Ezrin drives adaptation of monocytes to the inflamed lung microenvironment. Cell Death & Disease 2024, 15: 864. PMID: 39613751, PMCID: PMC11607083, DOI: 10.1038/s41419-024-07255-8.
- Prospective and External Validation of an Ensemble Learning Approach to Sensitively Detect Intravenous Fluid Contamination in Basic Metabolic PanelsSpies N, Militello L, Farnsworth C, El-Khoury J, Durant T, Zaydman M. Prospective and External Validation of an Ensemble Learning Approach to Sensitively Detect Intravenous Fluid Contamination in Basic Metabolic Panels. Clinical Chemistry 2024, 71: 296-306. PMID: 39545815, DOI: 10.1093/clinchem/hvae168.
- Abstract 4144255: Treatment of Human Engineered Heart Tissue with Serum from Cancer Patients with Clonal Hematopoiesis of Indeterminate Potential Cytokine Leads to Impaired FunctionKaur H, Halder S, Espinoza J, Chen N, VanOudenhove J, Biancon G, Gu S, Chakraborty R, Jain K, Park J, Qyang Y, Ibrahim E, Halene S, Hwa J, Campbell S, Jha A, Kwan J. Abstract 4144255: Treatment of Human Engineered Heart Tissue with Serum from Cancer Patients with Clonal Hematopoiesis of Indeterminate Potential Cytokine Leads to Impaired Function. Circulation 2024, 150: a4144255-a4144255. DOI: 10.1161/circ.150.suppl_1.4144255.
- Abstract 4147691: Sex-specific Thresholds for Energy Loss Index to Predict Survival in Paradoxical Low Flow Low Gradient Severe Aortic StenosisDahan S, Bach R, Namasivayam M, Tran N, Levine R, Hung J, Dal-Bianco J. Abstract 4147691: Sex-specific Thresholds for Energy Loss Index to Predict Survival in Paradoxical Low Flow Low Gradient Severe Aortic Stenosis. Circulation 2024, 150: a4147691-a4147691. DOI: 10.1161/circ.150.suppl_1.4147691.
- Detection of Live Attenuated Measles Virus in the Respiratory Tract Following Subcutaneous Measles-Mumps-Rubella VaccinationWatkins T, Brockhurst J, Germain G, Griffin D, Foxman E. Detection of Live Attenuated Measles Virus in the Respiratory Tract Following Subcutaneous Measles-Mumps-Rubella Vaccination. The Journal Of Infectious Diseases 2024, jiae537. PMID: 39504437, DOI: 10.1093/infdis/jiae537.
- Prophylactic Red Cell Exchange: Preventing Complications in Pregnant Patients with Sickle Cell DiseaseNurefsan Sariipek, Erin Horstman, Christopher Tormey, Nalan Yurtsever; Prophylactic Red Cell Exchange: Preventing Complications in Pregnant Patients with Sickle Cell Disease. Blood 2024; 144 (Supplement 1): 5340. doi: https://doi.org/10.1182/blood-2024-198650
- Prophylactic Red Cell Exchange: Preventing Complications in Pregnant Patients with Sickle Cell DiseaseSariipek N, Horstman E, Tormey C, Yurtsever N. Prophylactic Red Cell Exchange: Preventing Complications in Pregnant Patients with Sickle Cell Disease. Blood 2024, 144: 5340-5340. DOI: 10.1182/blood-2024-198650.
- Gene Copy Number Alterations Identify Subsets of Mycosis Fungoides/Sézary Syndrome Patients with Worse Survival OutcomesKiwan A, Kewan T, Xu M, Siddon A, Girardi M, Sethi T, Foss F. Gene Copy Number Alterations Identify Subsets of Mycosis Fungoides/Sézary Syndrome Patients with Worse Survival Outcomes. Blood 2024, 144: 4440-4440. DOI: 10.1182/blood-2024-205144.
- Clinically Driven Algorithms Identify Patients with Large Granular Lymphocytic Leukemia at Risk of Significant Cytopenia Requiring TreatmentKiwan A, Kewan T, Bravo-Perez C, Visconte V, Gurnari C, Durmaz A, Siddon A, Halene S, Sethi T, Maciejewski J, Foss F. Clinically Driven Algorithms Identify Patients with Large Granular Lymphocytic Leukemia at Risk of Significant Cytopenia Requiring Treatment. Blood 2024, 144: 4436. DOI: 10.1182/blood-2024-209344.
- Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH InhibitorsGoldberg L, Yoon J, Johnston H, Davidson M, Siddon A, Shallis R, Chen E, Burkart M, Oh T, Iyer S, Madarang E, Muthiah C, Kassner J, Rampal R, Guru Murthy G, Bradley T, Abaza Y, Garcia J, Gupta V, Pettit K, Odenike O, Cursio J, Patel A. Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH Inhibitors. Blood 2024, 144: 1787-1787. DOI: 10.1182/blood-2024-197898.
- Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective StudyCohen-Nowak A, Coltoff A, Patel A, Atallah E, El Kettani M, Wang J, Symes E, Venkataraman G, Siddon A, Giever E, Shallis R, Altman J, Bell-Burdett K, Badar T, Aqil B, Abaza Y. Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective Study. Blood 2024, 144: 2801-2801. DOI: 10.1182/blood-2024-199377.
- CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitorsKwon N, Lu Y, Thompson E, Mancuso R, Wang L, Zhang P, Krause D. CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors. Blood 2024, 144: 1800-1812. PMID: 39102635, PMCID: PMC11530366, DOI: 10.1182/blood.2024023963.
- Overall survival in TP53-mutated AML and MDSPuzo C, Hager K, Rinder H, Weinberg O, Siddon A. Overall survival in TP53-mutated AML and MDS. Annals Of Hematology 2024, 103: 5359-5369. PMID: 39443370, DOI: 10.1007/s00277-024-06054-7.
- An Opportunity for Developing Cancer Prevention Leadership in MexicoML V, N R, JA T, M P, D C, JE B, MA J, M A, A M, S A, S O, O A, LA H, E H, S C. An Opportunity for Developing Cancer Prevention Leadership in Mexico. Journal Of Cancer Education 2024, 1-7. PMID: 39446268, DOI: 10.1007/s13187-024-02525-7.
- Optimization criteria for ordering myeloid neoplasm next‐generation sequencingGisriel S, Howe J, Tormey C, Torres R, Hager K, Rinder H, Siddon A. Optimization criteria for ordering myeloid neoplasm next‐generation sequencing. EJHaem 2024, 5: 1236-1242. PMID: 39691272, PMCID: PMC11647727, DOI: 10.1002/jha2.1036.
- Differences Between Serum and Plasma: An Indirect Approach to Derive a Combined Reference Interval for Total Protein, Albumin, and GlobulinMilitello L, El-Khoury J, Durant T. Differences Between Serum and Plasma: An Indirect Approach to Derive a Combined Reference Interval for Total Protein, Albumin, and Globulin. American Journal Of Clinical Pathology 2024, 162: s170-s170. DOI: 10.1093/ajcp/aqae129.373.
- Assessing the Effect of Changing the Average Hematocrit in Red Blood Cell (RBC) Units on the Post- Procedure Hematocrits of Patients Undergoing ErythrocytapheresisMusante K, Roome L, Yurtsever N, Rinder H, Tormey C, Lee E. Assessing the Effect of Changing the Average Hematocrit in Red Blood Cell (RBC) Units on the Post- Procedure Hematocrits of Patients Undergoing Erythrocytapheresis. American Journal Of Clinical Pathology 2024, 162: s147-s147. DOI: 10.1093/ajcp/aqae129.326.
- Hematocrits of red blood cell units increase during storage due to changes in mean corpuscular volume, impacting outcomes of red cell exchange proceduresLee E, Musante K, Errico J, Rinder H, Kleinstein S, Tormey C, Yurtsever N. Hematocrits of red blood cell units increase during storage due to changes in mean corpuscular volume, impacting outcomes of red cell exchange procedures. American Journal Of Clinical Pathology 2024, 162: s157-s157. DOI: 10.1093/ajcp/aqae129.348.
- Flow cytometry for RBC damage and complement activationVillalba C, Yurtsever N, Paternoster K, Gallipoli P, Nash B, Bizzario L, Shah B, Rinder H, Tormey C, Lee E. Flow cytometry for RBC damage and complement activation. American Journal Of Clinical Pathology 2024, 162: s182-s183. DOI: 10.1093/ajcp/aqae129.400.
- Lost in the Ds: Unexplained Loss of Rh(D) Antigen Expression By Serological Testing In Two PatientsCarmichael G, Lee E, Tormey C, Yurtsever N, Shah B, Bizzario L. Lost in the Ds: Unexplained Loss of Rh(D) Antigen Expression By Serological Testing In Two Patients. American Journal Of Clinical Pathology 2024, 162: s148-s148. DOI: 10.1093/ajcp/aqae129.329.
- Laboratory Anomalies in the Basic Metabolic Panel: Core Curriculum 2025Takieddine L, El-Khoury J. Laboratory Anomalies in the Basic Metabolic Panel: Core Curriculum 2025. American Journal Of Kidney Diseases 2024, 85: 104-114. PMID: 39396361, DOI: 10.1053/j.ajkd.2024.06.019.
- High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional seriesEpperla N, Zayac A, Landsburg D, Bock A, Nowakowski G, Ayers E, Girton M, Hu M, Beckman A, Li S, Medeiros L, Chang J, Kurt H, Sandoval-Sus J, Ansari-Lari M, Kothari S, Kress A, Xu M, Torka P, Sundaram S, Smith S, Naresh K, Karimi Y, Bond D, Evens A, Naik S, Kamdar M, Haverkos B, Karmali R, Farooq U, Vose J, Rubinstein P, Chaudhry A, Olszewski A. High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series. Blood Advances 2024, 8: 5355-5364. PMID: 39189932, PMCID: PMC11568788, DOI: 10.1182/bloodadvances.2024013791.
- CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsSkoulidis F, Araujo H, Do M, Qian Y, Sun X, Cobo A, Le J, Montesion M, Palmer R, Jahchan N, Juan J, Min C, Yu Y, Pan X, Arbour K, Vokes N, Schmidt S, Molkentine D, Owen D, Memmott R, Patil P, Marmarelis M, Awad M, Murray J, Hellyer J, Gainor J, Dimou A, Bestvina C, Shu C, Riess J, Blakely C, Pecot C, Mezquita L, Tabbó F, Scheffler M, Digumarthy S, Mooradian M, Sacher A, Lau S, Saltos A, Rotow J, Johnson R, Liu C, Stewart T, Goldberg S, Killam J, Walther Z, Schalper K, Davies K, Woodcock M, Anagnostou V, Marrone K, Forde P, Ricciuti B, Venkatraman D, Van Allen E, Cummings A, Goldman J, Shaish H, Kier M, Katz S, Aggarwal C, Ni Y, Azok J, Segal J, Ritterhouse L, Neal J, Lacroix L, Elamin Y, Negrao M, Le X, Lam V, Lewis W, Kemp H, Carter B, Roth J, Swisher S, Lee R, Zhou T, Poteete A, Kong Y, Takehara T, Paula A, Parra Cuentas E, Behrens C, Wistuba I, Zhang J, Blumenschein G, Gay C, Byers L, Gibbons D, Tsao A, Lee J, Bivona T, Camidge D, Gray J, Leighl N, Levy B, Brahmer J, Garassino M, Gandara D, Garon E, Rizvi N, Scagliotti G, Wolf J, Planchard D, Besse B, Herbst R, Wakelee H, Pennell N, Shaw A, Jänne P, Carbone D, Hellmann M, Rudin C, Albacker L, Mann H, Zhu Z, Lai Z, Stewart R, Peters S, Johnson M, Wong K, Huang A, Winslow M, Rosen M, Winters I, Papadimitrakopoulou V, Cascone T, Jewsbury P, Heymach J. CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature 2024, 635: 462-471. PMID: 39385035, PMCID: PMC11560846, DOI: 10.1038/s41586-024-07943-7.
- Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic SyndromesKomrokji R, Lanino L, Ball S, Bewersdorf J, Marchetti M, Maggioni G, Travaglino E, Al Ali N, Fenaux P, Platzbecker U, Santini V, Diez-Campelo M, Singh A, Jain A, Aguirre L, Tinsley-Vance S, Schwabkey Z, Chan O, Xie Z, Brunner A, Kuykendall A, Bennett J, Buckstein R, Bejar R, Carraway H, DeZern A, Griffiths E, Halene S, Hasserjian R, Lancet J, List A, Loghavi S, Odenike O, Padron E, Patnaik M, Roboz G, Stahl M, Sekeres M, Steensma D, Savona M, Taylor J, Xu M, Sweet K, Sallman D, Nimer S, Hourigan C, Wei A, Sauta E, D’Amico S, Asti G, Castellani G, Delleani M, Campagna A, Borate U, Sanz G, Efficace F, Gore S, Kim T, Daver N, Garcia-Manero G, Rozman M, Orfao A, Wang A, Foucar M, Germing U, Haferlach T, Scheinberg P, Miyazaki Y, Iastrebner M, Kulasekararaj A, Cluzeau T, Kordasti S, van de Loosdrecht A, Ades L, Zeidan A, Della Porta M, Syndromes I. Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes. The Lancet Haematology 2024, 11: e862-e872. PMID: 39393368, DOI: 10.1016/s2352-3026(24)00251-5.
- CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and cystic fibrosis miceÖz H, Braga C, Gudneppanavar R, Di Pietro C, Huang P, Zhang P, Krause D, Egan M, Murray T, Bruscia E. CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and cystic fibrosis mice. Journal Of Leukocyte Biology 2024, 117: qiae218. PMID: 39365279, DOI: 10.1093/jleuko/qiae218.
- Persistent bloodstream infection in children: examining the role for repeat blood culturesPuthawala C, Feinn R, Rivera-Viñas J, Lee H, Murray T, Peaper D. Persistent bloodstream infection in children: examining the role for repeat blood cultures. Journal Of Clinical Microbiology 2024, 62: e00998-24. PMID: 39365070, PMCID: PMC11559050, DOI: 10.1128/jcm.00998-24.
- Dendritic cells in a pinch: Migration during homeostasis.Olson E, Eisenbarth S. Dendritic cells in a pinch: Migration during homeostasis. Science Immunology 2024, 9: eadt3806. PMID: 39365873, DOI: 10.1126/sciimmunol.adt3806.
- B-030 Performance evaluation of Siemens Atellica® IM Anti-Müllerian Hormone AssayShang E, Agustin H, El-Khoury J, Lee J, Jones J, Scheidegger M, Abou-Diwan C, Rhea-McManus J, Li J. B-030 Performance evaluation of Siemens Atellica® IM Anti-Müllerian Hormone Assay. Clinical Chemistry 2024, 70: hvae106.394. DOI: 10.1093/clinchem/hvae106.394.
- S4657 Heterogeneous Tumor Profiles in Hepatocellular Carcinoma: An Example of Late Recurrences With Genetically Distinct TumorsCao Y, Laurans M, Walther Z, Zhang X, Rose M, Taddei T. S4657 Heterogeneous Tumor Profiles in Hepatocellular Carcinoma: An Example of Late Recurrences With Genetically Distinct Tumors. The American Journal Of Gastroenterology 2024, 119: s2949-s2949. DOI: 10.14309/01.ajg.0001047996.50296.20.
- Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissuesBai Z, Zhang D, Gao Y, Tao B, Zhang D, Bao S, Enninful A, Wang Y, Li H, Su G, Tian X, Zhang N, Xiao Y, Liu Y, Gerstein M, Li M, Xing Y, Lu J, Xu M, Fan R. Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues. Cell 2024, 187: 6760-6779.e24. PMID: 39353436, PMCID: PMC11568911, DOI: 10.1016/j.cell.2024.09.001.
- Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJacobs J, Booth G, Raza S, Clark L, Fasano R, Gavriilaki E, Abels E, Binns T, Duque M, McQuilten Z, Mingot‐Castellano M, Savani B, Sharma D, Tran M, Tormey C, Moise K, Bloch E, Adkins B. Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions. American Journal Of Hematology 2024, 99: 2351-2366. PMID: 39324647, PMCID: PMC11560617, DOI: 10.1002/ajh.27487.
- Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])Aakash F, Gisriel S, Zeidan A, Bennett J, Bejar R, Bewersdorf J, Borate U, Boultwood J, Brunner A, Buckstein R, Carraway H, Churpek J, Daver N, DeZern A, Efficace F, Fenaux P, Figueroa M, Garcia-Manero G, Gore S, Greenberg P, Griffiths E, Halene S, Hourigan C, Kim T, Kim N, Komrokji R, Kutchroo V, List A, Little R, Majeti R, Nazha A, Nimer S, Odenike O, Padron E, Patnaik M, Platzbecker U, Della Porta M, Roboz G, Sallman D, Santini V, Sanz G, Savona M, Sekeres M, Stahl M, Starczynowski D, Steensma D, Taylor J, Abdel-Wahab O, Wei A, Xie Z, Xu M, Hasserjian R, Loghavi S. Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]). Modern Pathology 2024, 37: 100615. PMID: 39322118, DOI: 10.1016/j.modpat.2024.100615.
- The effect of plerixafor on autologous stem cell mobilization, cell viability, and apheresis challengesPuzo C, Li P, Tormey C, Siddon A. The effect of plerixafor on autologous stem cell mobilization, cell viability, and apheresis challenges. Lab Medicine 2024, 56: 187-194. PMID: 39303673, DOI: 10.1093/labmed/lmae080.
- Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networksLu Y, Keeley E, Barrette E, Cooper-DeHoff R, Dhruva S, Gaffney J, Gamble G, Handke B, Huang C, Krumholz H, McDonough C, Schulz W, Shaw K, Smith M, Woodard J, Young P, Ervin K, Ross J. Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networks. BMC Cardiovascular Disorders 2024, 24: 497. PMID: 39289597, PMCID: PMC11409735, DOI: 10.1186/s12872-024-04161-x.
- Scaleable production of highly loaded protein nanoparticles for immune modulationCaplan M, Baldwin R, Yin X, Grishin A, Eisenbarth S, Sampson H, Bottomly K, Prud’homme R. Scaleable production of highly loaded protein nanoparticles for immune modulation. Communications Materials 2024, 5: 191. DOI: 10.1038/s43246-024-00626-w.
- Genome-wide association study between SARS-CoV-2 single nucleotide polymorphisms and virus copies during infectionsLi K, Chaguza C, Stamp J, Chew Y, Chen N, Ferguson D, Pandya S, Kerantzas N, Schulz W, Initiative Y, Hahn A, Ogbunugafor C, Pitzer V, Crawford L, Weinberger D, Grubaugh N. Genome-wide association study between SARS-CoV-2 single nucleotide polymorphisms and virus copies during infections. PLOS Computational Biology 2024, 20: e1012469. PMID: 39288189, PMCID: PMC11432881, DOI: 10.1371/journal.pcbi.1012469.
- Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studiesGu S, Butt A, Schulz V, Rinder H, Lee A, Gallagher P, Hwa J, Bona R. Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies. Blood Cells Molecules And Diseases 2024, 110: 102893. PMID: 39260211, DOI: 10.1016/j.bcmd.2024.102893.
- Increased autoreactivity and maturity of EBI2+ antibody-secreting cells from nasal polypsBai J, Kato A, Hulse K, Wechsler J, Gujar V, Poposki J, Harmon R, Iwasaki N, Wang B, Huang J, Stevens W, Conley D, Welch K, Kern R, Peters A, Eisenbarth S, Schleimer R, Tan B. Increased autoreactivity and maturity of EBI2+ antibody-secreting cells from nasal polyps. JCI Insight 2024, 9: e177729. PMID: 39253973, PMCID: PMC11385095, DOI: 10.1172/jci.insight.177729.
- Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United StatesJacobs J, Booth G, Moise K, Adkins B, Bakhtary S, Fasano R, Goel R, Hinton H, Laghari S, Stephens L, Tormey C, Crowe E, Bloch E, Abels E. Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States. Transfusion 2024, 64: 1870-1880. PMID: 39248602, DOI: 10.1111/trf.18011.
- Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insightsMuradashvili T, Liu Y, VanOudenhove J, Gu S, Krause D, Montanari F, Carlino M, Mancuso R, Stempel J, Halene S, Zeidan A, Podoltsev N, Neparidze N. Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights. Leukemia & Lymphoma 2024, 65: 2182-2189. PMID: 39225418, DOI: 10.1080/10428194.2024.2393260.
- Breaking the Chain: Navigating the Pitfalls of Total Laboratory AutomationEl-Khoury J. Breaking the Chain: Navigating the Pitfalls of Total Laboratory Automation. The Journal Of Applied Laboratory Medicine 2024, 9: 1095-1096. PMID: 39225460, DOI: 10.1093/jalm/jfae061.
- ADLM Guidance Document on the Measurement and Reporting of Lipids and LipoproteinsCao J, Donato L, El-Khoury J, Goldberg A, Meeusen J, Remaley A. ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins. The Journal Of Applied Laboratory Medicine 2024, 9: 1040-1056. PMID: 39225455, DOI: 10.1093/jalm/jfae057.
- Early AI Lifecycle Co-Reasoning: Ethics Through Integrated and Diverse Team SciencePacia D, Ravitsky V, Hansen J, Lundberg E, Schulz W, Bélisle-Pipon J. Early AI Lifecycle Co-Reasoning: Ethics Through Integrated and Diverse Team Science. The American Journal Of Bioethics 2024, 24: 86-88. PMID: 39226006, DOI: 10.1080/15265161.2024.2377106.
- 395 Altered hematopoiesis and functional decline of hematopoietic stem cells in cystic fibrosis miceBraga C, Mancuso R, Thompson E, Oez H, Gudneppannavar R, Zhang P, Huang P, Egan M, Murray T, Krause D, Bruscia E. 395 Altered hematopoiesis and functional decline of hematopoietic stem cells in cystic fibrosis mice. Journal Of Cystic Fibrosis 2024, 23: s207-s208. DOI: 10.1016/s1569-1993(24)01235-9.
- Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantationYurtsever N, Lee E, Pinatti L, Shah B, Tormey C, Siddon A. Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation. Immunohematology 2024, 40: 89-92. PMID: 39373301, PMCID: PMC11700658, DOI: 10.2478/immunohematology-2024-013.
- Direct analysis in real time mass spectrometry (DART-MS/MS) for rapid urine opioid detection in a clinical settingChoucair I, Shang E, Tran M, Cassella-McLane G, El-Khoury J. Direct analysis in real time mass spectrometry (DART-MS/MS) for rapid urine opioid detection in a clinical setting. Clinica Chimica Acta 2024, 564: 119939. PMID: 39197698, DOI: 10.1016/j.cca.2024.119939.
- High-Dimensional Single-Cell Mass Cytometry Demonstrates Differential Platelet Functional Phenotypes in Infants With Congenital Heart DiseaseGu S, Marcus B, Gu V, Varghese A, Hwa J, Faustino E. High-Dimensional Single-Cell Mass Cytometry Demonstrates Differential Platelet Functional Phenotypes in Infants With Congenital Heart Disease. Arteriosclerosis Thrombosis And Vascular Biology 2024, 44: 2530-2539. PMID: 39171400, PMCID: PMC11602369, DOI: 10.1161/atvbaha.124.321131.
- The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodesJacobs J, Stanek C, Booth G, Symeonidis A, Shih A, Allen E, Gavriilaki E, Grossman B, Pavenski K, Moorehead A, Peyvandi F, Agosti P, Mancini I, Stephens L, Raval J, Mingot‐Castellano M, Crowe E, Daou L, Pai M, Arnold D, Marques M, Henrie R, Smith T, Sreenivasan G, Siniard R, Wallace L, Yamada C, Duque M, Wu Y, Harrington T, Byrnes D, Bitsani A, Davis A, Robinson D, Eichbaum Q, Villalba C, Juskewitch J, Kaiafa G, Kapsali E, Klapper E, Perez‐Alvarez I, Klein M, Kotsiou N, Lalayanni C, Mandala E, Aldarweesh F, Alkhateb R, Fortuny L, Mellios Z, Papalexandri A, Parsons M, Schlueter A, Tormey C, Wellard C, Wood E, Jia S, Wheeler A, Powers A, Webb C, Yates S, Bouzid R, Coppo P, Bloch E, Adkins B. The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes. American Journal Of Hematology 2024, 99: 2063-2074. PMID: 39136282, DOI: 10.1002/ajh.27458.
- Addressing platelet insecurity – A national call to actionGehrie E, Young P, Basavaraju S, Bracey A, P. A, Culler L, Dunbar N, Homer M, Isufi I, Macedo R, Petraszko T, Ramsey G, Tormey C, Kaufman R, Snyder E. Addressing platelet insecurity – A national call to action. Transfusion 2024, 64: 2001-2013. PMID: 39133194, PMCID: PMC11921857, DOI: 10.1111/trf.17987.
- Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trialJacobs J, Booth G, Stephens L, Tormey C, Adkins B. Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial. The Lancet 2024, 404: 433. PMID: 39097393, DOI: 10.1016/s0140-6736(24)01264-9.
- 3109 – OPTIMIZING AND SIMPLIFYING READOUT OF HEMATOPOIETIC COLONY FORMING UNIT (CFU) ASSAYSKrause D, Thompson E, Carlino M, Scanlon V. 3109 – OPTIMIZING AND SIMPLIFYING READOUT OF HEMATOPOIETIC COLONY FORMING UNIT (CFU) ASSAYS. Experimental Hematology 2024, 137: 104431. DOI: 10.1016/j.exphem.2024.104431.
- 3046 – FUNCTIONAL CHARACTERIZATION OF RBM15-MKL1 FUSION PROTEIN IN AMKL TUMORIGENESISChen M, Mayday M, Espinosa A, Zhang M, Zhang P, Wang L, Rahman N, Krause D. 3046 – FUNCTIONAL CHARACTERIZATION OF RBM15-MKL1 FUSION PROTEIN IN AMKL TUMORIGENESIS. Experimental Hematology 2024, 137: 104368. DOI: 10.1016/j.exphem.2024.104368.
- TRF2–RAP1 represses RAD51-dependent homology-directed telomere repair by promoting BLM-mediated D-loop unwinding and inhibiting BLM–DNA2-dependent 5′-end resectionLiang F, Rai R, Sodeinde T, Chang S. TRF2–RAP1 represses RAD51-dependent homology-directed telomere repair by promoting BLM-mediated D-loop unwinding and inhibiting BLM–DNA2-dependent 5′-end resection. Nucleic Acids Research 2024, 52: 9695-9709. PMID: 39082275, PMCID: PMC11381343, DOI: 10.1093/nar/gkae642.
- SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacityPeña-Hernández M, Alfajaro M, Filler R, Moriyama M, Keeler E, Ranglin Z, Kong Y, Mao T, Menasche B, Mankowski M, Zhao Z, Vogels C, Hahn A, Kalinich C, Zhang S, Huston N, Wan H, Araujo-Tavares R, Lindenbach B, Homer R, Pyle A, Martinez D, Grubaugh N, Israelow B, Iwasaki A, Wilen C. SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacity. Nature Microbiology 2024, 9: 2038-2050. PMID: 39075235, DOI: 10.1038/s41564-024-01765-z.
- National rollout of a medication safety dashboard to improve testing for latent infections among biologic and targeted synthetic disease‐modifying agent users within the Veterans Health AdministrationSchmajuk G, Ware A, Li J, Tarasovsky G, Shiboski S, Barton J, Miller K, Mitchell H, Dana J, Reiter K, Wahl E, Rozenberg‐Ben‐Dror K, Hauser R, Whooley M. National rollout of a medication safety dashboard to improve testing for latent infections among biologic and targeted synthetic disease‐modifying agent users within the Veterans Health Administration. Health Services Research 2024, 60: e14363. PMID: 39056425, PMCID: PMC11782092, DOI: 10.1111/1475-6773.14363.
- All roads lead to IgA: Mapping the many pathways of IgA induction in the gutSiniscalco E, Williams A, Eisenbarth S. All roads lead to IgA: Mapping the many pathways of IgA induction in the gut. Immunological Reviews 2024, 326: 66-82. PMID: 39046160, DOI: 10.1111/imr.13369.
- ChatGPT: A Reliable Laboratory Medicine Consult?El-Khoury J. ChatGPT: A Reliable Laboratory Medicine Consult? Clinical Chemistry 2024, 70: 1089-1091. PMID: 39045739, DOI: 10.1093/clinchem/hvae100.
- Therapeutic plasma exchange for hyperviscosity syndrome in IgA multiple myelomaYurtsever N, Binns T, Hendrickson J, Tormey C, Lee E. Therapeutic plasma exchange for hyperviscosity syndrome in IgA multiple myeloma. Lab Medicine 2024, 56: 85-88. PMID: 39038224, DOI: 10.1093/labmed/lmae054.
- Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activationTrogdon M, Abbott K, Arang N, Lande K, Kaur N, Tong M, Bakhoum M, Gutkind J, Stites E. Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation. Npj Systems Biology And Applications 2024, 10: 75. PMID: 39013872, PMCID: PMC11252164, DOI: 10.1038/s41540-024-00400-1.
- Veteran's Health Administration HIV Care Continuum: 2019 vs 2022Maier M, Beste L, Lowy E, Hauser R, Van Epps P, Yakovchenko V, Rogal S, Chartier M, Ross D. Veteran's Health Administration HIV Care Continuum: 2019 vs 2022. Open Forum Infectious Diseases 2024, 11: ofae382. PMID: 39086463, PMCID: PMC11288371, DOI: 10.1093/ofid/ofae382.
- Human red blood cells express the RNA sensor TLR7Metthew Lam L, Oatman E, Eckart K, Klingensmith N, Flowers E, Sayegh L, Yuen J, Clements R, Meyer N, Jurado K, Vaughan A, Eisenbarth S, Mangalmurti N. Human red blood cells express the RNA sensor TLR7. Scientific Reports 2024, 14: 15789. PMID: 38982195, PMCID: PMC11233670, DOI: 10.1038/s41598-024-66410-5.
- A multi‐institutional survey of apheresis services among institutions in the United StatesYurtsever N, Jacobs J, Booth G, Schwartz J, Park Y, Woo J, Lauro D, Torres S, Ward D, Stephens L, Allen E, Tormey C, Adkins B. A multi‐institutional survey of apheresis services among institutions in the United States. Journal Of Clinical Apheresis 2024, 39: e22138. PMID: 38979705, DOI: 10.1002/jca.22138.
- Accounting for differences between serum and plasma: An indirect approach to derive reference intervals for total protein, albumin, and globulinMilitello L, El-Khoury J, Durant T. Accounting for differences between serum and plasma: An indirect approach to derive reference intervals for total protein, albumin, and globulin. Clinica Chimica Acta 2024, 562: 119851. PMID: 38977172, DOI: 10.1016/j.cca.2024.119851.
- Dendritic cells in food allergy, treatment, and toleranceLiu E, Yin X, Siniscalco E, Eisenbarth S. Dendritic cells in food allergy, treatment, and tolerance. Journal Of Allergy And Clinical Immunology 2024, 154: 511-522. PMID: 38971539, PMCID: PMC11414995, DOI: 10.1016/j.jaci.2024.06.017.
- Red Cell Damage During Extracorporeal Life Support.Figueroa Villalba CA, Saifee NH, Chandler WL. Red Cell Damage During Extracorporeal Life Support. ASAIO J 2024 PMID: 38950201, DOI: 10.1097/MAT.0000000000002265.
- High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in childrenWatkins T, Green A, Amat J, Cheemarla N, Hänsel K, Lozano R, Dudgeon S, Germain G, Landry M, Schulz W, Foxman E. High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children. Journal Of Experimental Medicine 2024, 221: e20230911. PMID: 38949638, PMCID: PMC11215523, DOI: 10.1084/jem.20230911.
- A primer for quantum computing and its applications to healthcare and biomedical researchDurant T, Knight E, Nelson B, Dudgeon S, Lee S, Walliman D, Young H, Ohno-Machado L, Schulz W. A primer for quantum computing and its applications to healthcare and biomedical research. Journal Of The American Medical Informatics Association 2024, 31: 1774-1784. PMID: 38934288, PMCID: PMC11258415, DOI: 10.1093/jamia/ocae149.
- Large B‐cell lymphoma with mystery rearrangement: Applying Hi‐C to the detection of clinically relevant structural abnormalitiesPrior D, Schmitt A, Louissaint A, Mata D, Massaro S, Nardi V, Xu M. Large B‐cell lymphoma with mystery rearrangement: Applying Hi‐C to the detection of clinically relevant structural abnormalities. British Journal Of Haematology 2024, 205: 1225-1229. PMID: 38924537, DOI: 10.1111/bjh.19611.
- Puzzling undetectable haptoglobin in a transfused pregnant patientChaves Rivera M, Choucair I, Vera M, El-Khoury J, Figueroa Villalba C. Puzzling undetectable haptoglobin in a transfused pregnant patient. Clinica Chimica Acta 2024, 561: 119829. PMID: 38917868, DOI: 10.1016/j.cca.2024.119829.
- Cancer research is not correlated with driver gene mutation burdensMendiratta G, Liarakos D, Tong M, Ito S, Ke E, Goshua G, Stites E. Cancer research is not correlated with driver gene mutation burdens. Med 2024, 5: 832-838.e4. PMID: 38908369, DOI: 10.1016/j.medj.2024.05.013.
- Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatmentBoyce J, Eisenbarth S. Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment. Journal Of Clinical Investigation 2024, 134: e182410. PMID: 40047886, PMCID: PMC11178525, DOI: 10.1172/jci182410.
- Rare Drivers at Low Prevalence with High Cancer Effects in T-Cell and B-Cell Pediatric Acute Lymphoblastic LeukemiaMandell J, Diviti S, Xu M, Townsend J. Rare Drivers at Low Prevalence with High Cancer Effects in T-Cell and B-Cell Pediatric Acute Lymphoblastic Leukemia. International Journal Of Molecular Sciences 2024, 25: 6589. PMID: 38928295, PMCID: PMC11203805, DOI: 10.3390/ijms25126589.
- Mitral Annular Calcification and Valve Dysfunction: Insights and Future DirectionsDal-Bianco J, Levine R, Hung J. Mitral Annular Calcification and Valve Dysfunction: Insights and Future Directions. Journal Of The American Society Of Echocardiography 2024, 37: 756-758. PMID: 38871339, DOI: 10.1016/j.echo.2024.06.002.
- Updated pathophysiological overview of functional MR (ventricular and atrial)Akashi J, Otsuji Y, Nishimura Y, Levine R, Kataoka M. Updated pathophysiological overview of functional MR (ventricular and atrial). General Thoracic And Cardiovascular Surgery 2024, 73: 1-11. PMID: 38858323, DOI: 10.1007/s11748-024-02047-5.
- The aMPPle differentiation potential of TH2 cells in human allergy.Siddapureddy S, Eisenbarth S. The aMPPle differentiation potential of TH2 cells in human allergy. Science Immunology 2024, 9: eadq7287. PMID: 38848341, DOI: 10.1126/sciimmunol.adq7287.
